COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF CARDIOPULMONARY AND RENAL FAILURE OR DAMAGE ASSOCIATED WITH ISCHEMIA, ENDOTOXIN RELEASE, ARDS OR BROUGHT ABOUT BY ADMINISTRATION OF CERTAIN DRUGS

WIPO Patent Application WO1999063938

A9

A pharmaceutical composition comprises an agent such as an adenosine A2a agonist agent and/or nucleic acid comprising an oligonucleotide(oligo) that is anti-sense to an adenosine A1, A2a, A2b or A3 receptor gene, mRNA, flanking regions or regions bridging the intro/exon borders, which oligos are effective to prevent, alleviate or inhibit adenosine-mediated cardiac, pulmonary and/or renal functional difficulties, damage or failure, such as those observed in diseases and conditions such as ARDS, hypoxia, etc. or associated with the administration of therapeutic and diagnostic agents such as adenosine cysplatin, metal ion-containing agents, etc., mixtures thereof, and optionally a surfactant, a carrier and other therapeutic and diagnostic agents and other formulation components. The composition is provided in the form of various formulations that are, for example, effective for preventing or alleviating bronchoconstriction, allergy and/or inflammation associated with ARDS, RDS, etc., deleterious side effects observed upon treatment of SVT patients, upon administration of cardiac stress tests or imaging tests, etc.

NYCE JONATHAN W (US)
HILL JEFFREY L (US)

PCT/US1999/012775

March 02, 2000

June 08, 1999

Click for automatic bibliography generation  

EPIGENESIS PHARMACEUTICALS INC (US)
NYCE JONATHAN W (US)
HILL JEFFREY L (US)

A61K31/00; A61K45/06; C12N15/113; A61K38/00; (IPC1-7): A61K48/00; C07H21/00; C07H21/04; C12N5/00; C12N15/09; C12N15/63; C12N15/79

View/Download PDF      PDF Help

Previous Patent: MULTIVALENT MACROLIDE ANTIBIOTICS

Next Patent: MULTIBINDING INHIBITORS OF CYCLOOXYGENASE-2